

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phototransduction (GO:0007602) | 9.18240998 |
| 2 | phototransduction, visible light (GO:0007603) | 9.12190106 |
| 3 | GMP metabolic process (GO:0046037) | 9.07935103 |
| 4 | detection of visible light (GO:0009584) | 9.05021447 |
| 5 | detection of light stimulus (GO:0009583) | 9.03061601 |
| 6 | positive regulation of guanylate cyclase activity (GO:0031284) | 8.37161649 |
| 7 | protein-chromophore linkage (GO:0018298) | 8.26112060 |
| 8 | visual perception (GO:0007601) | 8.00170614 |
| 9 | sensory perception of light stimulus (GO:0050953) | 7.92666113 |
| 10 | regulation of guanylate cyclase activity (GO:0031282) | 7.52190920 |
| 11 | photoreceptor cell differentiation (GO:0046530) | 6.66209599 |
| 12 | eye photoreceptor cell differentiation (GO:0001754) | 6.66209599 |
| 13 | cellular response to light stimulus (GO:0071482) | 6.63331066 |
| 14 | detection of external stimulus (GO:0009581) | 6.32256771 |
| 15 | detection of abiotic stimulus (GO:0009582) | 6.21190685 |
| 16 | retina development in camera-type eye (GO:0060041) | 6.17886795 |
| 17 | regulation of cGMP metabolic process (GO:0030823) | 6.00666888 |
| 18 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.66237327 |
| 19 | regulation of cGMP biosynthetic process (GO:0030826) | 5.29362122 |
| 20 | positive regulation of cGMP metabolic process (GO:0030825) | 4.99803975 |
| 21 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.73382379 |
| 22 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.71935328 |
| 23 | nonmotile primary cilium assembly (GO:0035058) | 4.63430448 |
| 24 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.49488741 |
| 25 | cellular response to radiation (GO:0071478) | 4.21483292 |
| 26 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.91981621 |
| 27 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.86224031 |
| 28 | sensory perception (GO:0007600) | 3.76577253 |
| 29 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 3.74425325 |
| 30 | adaptation of signaling pathway (GO:0023058) | 3.65879107 |
| 31 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.58843683 |
| 32 | protein localization to synapse (GO:0035418) | 3.53677281 |
| 33 | response to light stimulus (GO:0009416) | 3.45293678 |
| 34 | protein prenylation (GO:0018342) | 3.44891018 |
| 35 | prenylation (GO:0097354) | 3.44891018 |
| 36 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.37785319 |
| 37 | neuron development (GO:0048666) | 3.35641177 |
| 38 | cellular potassium ion homeostasis (GO:0030007) | 3.32193898 |
| 39 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.31947682 |
| 40 | estrogen biosynthetic process (GO:0006703) | 3.30079284 |
| 41 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.28159663 |
| 42 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.28159663 |
| 43 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.24162958 |
| 44 | retina homeostasis (GO:0001895) | 3.19646883 |
| 45 | retina layer formation (GO:0010842) | 3.12501977 |
| 46 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.08404579 |
| 47 | response to pheromone (GO:0019236) | 3.07768564 |
| 48 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.93642034 |
| 49 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.91956768 |
| 50 | regulation of bile acid biosynthetic process (GO:0070857) | 2.90814832 |
| 51 | behavioral response to ethanol (GO:0048149) | 2.89841030 |
| 52 | response to histamine (GO:0034776) | 2.89160871 |
| 53 | sodium ion export (GO:0071436) | 2.87094833 |
| 54 | retinoid metabolic process (GO:0001523) | 2.86054091 |
| 55 | retinol metabolic process (GO:0042572) | 2.85604282 |
| 56 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.85486809 |
| 57 | potassium ion homeostasis (GO:0055075) | 2.83939290 |
| 58 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.81417597 |
| 59 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.78734776 |
| 60 | membrane hyperpolarization (GO:0060081) | 2.78127129 |
| 61 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.77615140 |
| 62 | diterpenoid metabolic process (GO:0016101) | 2.72921412 |
| 63 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.70889050 |
| 64 | short-term memory (GO:0007614) | 2.67235759 |
| 65 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.66918693 |
| 66 | lipoprotein transport (GO:0042953) | 2.64057591 |
| 67 | behavioral response to cocaine (GO:0048148) | 2.61335820 |
| 68 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.58906953 |
| 69 | lactate metabolic process (GO:0006089) | 2.58013149 |
| 70 | terpenoid metabolic process (GO:0006721) | 2.55927811 |
| 71 | positive regulation of neurotransmitter transport (GO:0051590) | 2.49162909 |
| 72 | regulation of penile erection (GO:0060405) | 2.48792428 |
| 73 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.46232724 |
| 74 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.46092496 |
| 75 | striatum development (GO:0021756) | 2.45351320 |
| 76 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.42391370 |
| 77 | chemosensory behavior (GO:0007635) | 2.35568287 |
| 78 | synaptic vesicle maturation (GO:0016188) | 2.35272524 |
| 79 | regulation of neurotransmitter uptake (GO:0051580) | 2.32790294 |
| 80 | response to radiation (GO:0009314) | 2.32136387 |
| 81 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.30603757 |
| 82 | synaptic transmission, dopaminergic (GO:0001963) | 2.27130491 |
| 83 | response to leptin (GO:0044321) | 2.26993425 |
| 84 | axoneme assembly (GO:0035082) | 2.26833607 |
| 85 | phospholipid translocation (GO:0045332) | 2.26644134 |
| 86 | lipid translocation (GO:0034204) | 2.26644134 |
| 87 | cellular response to leptin stimulus (GO:0044320) | 2.22559257 |
| 88 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.20709655 |
| 89 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.20709655 |
| 90 | fatty acid elongation (GO:0030497) | 2.20593131 |
| 91 | icosanoid secretion (GO:0032309) | 2.19865237 |
| 92 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 15.8429821 |
| 93 | rhodopsin mediated signaling pathway (GO:0016056) | 15.5157562 |
| 94 | retinal cone cell development (GO:0046549) | 13.5627915 |
| 95 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.6955423 |
| 96 | detection of light stimulus involved in visual perception (GO:0050908) | 11.6955423 |
| 97 | photoreceptor cell development (GO:0042461) | 11.3554490 |
| 98 | eye photoreceptor cell development (GO:0042462) | 10.9290783 |
| 99 | photoreceptor cell maintenance (GO:0045494) | 10.5466330 |
| 100 | retinal rod cell development (GO:0046548) | 10.1300209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.66911559 |
| 2 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.24680809 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.07103222 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.90588232 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73202942 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72789224 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.46116841 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10699173 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05466894 |
| 10 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.03347554 |
| 11 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.03036980 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92364296 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90221547 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.82020705 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.78337061 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74309533 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.72242376 |
| 18 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71085013 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70979525 |
| 20 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.67427856 |
| 21 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.65736514 |
| 22 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.63192450 |
| 23 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62658072 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61186916 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.59205581 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58496799 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.56417408 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53883055 |
| 29 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53336220 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53061583 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49782232 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42319361 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41469646 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40142096 |
| 35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38344108 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38217386 |
| 37 | AR_19668381_ChIP-Seq_PC3_Human | 1.36457611 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36167194 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35496868 |
| 40 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.34848569 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33864640 |
| 42 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25130633 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24824326 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23228649 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22211183 |
| 46 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.22122542 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20001755 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.17493555 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.17493555 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17224824 |
| 51 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.15803617 |
| 52 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13059459 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12884831 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12713742 |
| 55 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.12068219 |
| 56 | TBL1_22424771_ChIP-Seq_293T_Human | 1.11127497 |
| 57 | * CBP_21632823_ChIP-Seq_H3396_Human | 1.10861969 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10207434 |
| 59 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10127225 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08711792 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08019998 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08019998 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07609359 |
| 64 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07598252 |
| 65 | NCOR_22424771_ChIP-Seq_293T_Human | 1.06646121 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06487566 |
| 67 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06336051 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06251964 |
| 69 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05284652 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04040593 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03402194 |
| 72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03335198 |
| 73 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02457734 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01991657 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01352271 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01175002 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01036528 |
| 78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00816820 |
| 79 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.99829488 |
| 80 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.98819252 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98100418 |
| 82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96013367 |
| 83 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94715457 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94031530 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93942156 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91268185 |
| 87 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.90866071 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88509030 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87455836 |
| 90 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.86922465 |
| 91 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86416837 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86406747 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85298712 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84904216 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84348417 |
| 96 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84071145 |
| 97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83393783 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82815486 |
| 99 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.82712912 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81584867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 9.75804420 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 9.74212914 |
| 3 | MP0005253_abnormal_eye_physiology | 6.44179650 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 6.30914974 |
| 5 | MP0003950_abnormal_plasma_membrane | 4.16268352 |
| 6 | MP0005195_abnormal_posterior_eye | 3.84865897 |
| 7 | MP0002090_abnormal_vision | 3.43272154 |
| 8 | MP0001324_abnormal_eye_pigmentation | 3.39831215 |
| 9 | MP0002638_abnormal_pupillary_reflex | 3.11727971 |
| 10 | MP0005391_vision/eye_phenotype | 3.11189479 |
| 11 | MP0002229_neurodegeneration | 2.42252554 |
| 12 | MP0001764_abnormal_homeostasis | 2.41600688 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.16200227 |
| 14 | MP0002752_abnormal_somatic_nervous | 1.87331974 |
| 15 | MP0001502_abnormal_circadian_rhythm | 1.61550852 |
| 16 | MP0001984_abnormal_olfaction | 1.58878712 |
| 17 | MP0001986_abnormal_taste_sensitivity | 1.58368921 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.54235694 |
| 19 | MP0005365_abnormal_bile_salt | 1.51349584 |
| 20 | MP0005360_urolithiasis | 1.41175392 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 1.32259091 |
| 22 | MP0004233_abnormal_muscle_weight | 1.27309954 |
| 23 | MP0002882_abnormal_neuron_morphology | 1.27127022 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.26748509 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.25367759 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.20392628 |
| 27 | MP0003252_abnormal_bile_duct | 1.04585315 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.03580857 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.03163499 |
| 30 | MP0005499_abnormal_olfactory_system | 0.97768423 |
| 31 | MP0005394_taste/olfaction_phenotype | 0.97768423 |
| 32 | MP0005197_abnormal_uvea_morphology | 0.95755151 |
| 33 | MP0008789_abnormal_olfactory_epithelium | 0.90484773 |
| 34 | MP0002332_abnormal_exercise_endurance | 0.87593053 |
| 35 | MP0005187_abnormal_penis_morphology | 0.87341178 |
| 36 | MP0004885_abnormal_endolymph | 0.84104677 |
| 37 | MP0010386_abnormal_urinary_bladder | 0.84063322 |
| 38 | MP0010329_abnormal_lipoprotein_level | 0.78236325 |
| 39 | MP0005248_abnormal_Harderian_gland | 0.77525339 |
| 40 | MP0001486_abnormal_startle_reflex | 0.74326282 |
| 41 | MP0002272_abnormal_nervous_system | 0.70491405 |
| 42 | MP0003634_abnormal_glial_cell | 0.70428955 |
| 43 | MP0002127_abnormal_cardiovascular_syste | 0.67924546 |
| 44 | MP0003868_abnormal_feces_composition | 0.63745627 |
| 45 | MP0009840_abnormal_foam_cell | 0.62331439 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.58952935 |
| 47 | MP0010368_abnormal_lymphatic_system | 0.56199986 |
| 48 | MP0001286_abnormal_eye_development | 0.53312954 |
| 49 | MP0005595_abnormal_vascular_smooth | 0.52715041 |
| 50 | MP0002067_abnormal_sensory_capabilities | 0.52455592 |
| 51 | MP0009046_muscle_twitch | 0.50418961 |
| 52 | MP0002064_seizures | 0.49533463 |
| 53 | MP0009697_abnormal_copulation | 0.47327445 |
| 54 | MP0001963_abnormal_hearing_physiology | 0.46429166 |
| 55 | MP0002734_abnormal_mechanical_nocicepti | 0.46066553 |
| 56 | MP0003880_abnormal_central_pattern | 0.44974319 |
| 57 | MP0004036_abnormal_muscle_relaxation | 0.43925116 |
| 58 | MP0000631_abnormal_neuroendocrine_gland | 0.43835977 |
| 59 | MP0004270_analgesia | 0.42811042 |
| 60 | MP0004215_abnormal_myocardial_fiber | 0.41847913 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 0.40827635 |
| 62 | MP0001346_abnormal_lacrimal_gland | 0.37893369 |
| 63 | MP0003635_abnormal_synaptic_transmissio | 0.37422971 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 0.35615227 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 0.35305850 |
| 66 | MP0004085_abnormal_heartbeat | 0.35226756 |
| 67 | MP0002063_abnormal_learning/memory/cond | 0.34151171 |
| 68 | MP0005670_abnormal_white_adipose | 0.34044638 |
| 69 | MP0002184_abnormal_innervation | 0.33650744 |
| 70 | MP0001666_abnormal_nutrient_absorption | 0.32487658 |
| 71 | MP0005620_abnormal_muscle_contractility | 0.32302165 |
| 72 | MP0002928_abnormal_bile_duct | 0.32193221 |
| 73 | MP0008775_abnormal_heart_ventricle | 0.31579393 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 0.31118796 |
| 75 | MP0005332_abnormal_amino_acid | 0.31074369 |
| 76 | MP0003890_abnormal_embryonic-extraembry | 0.30971500 |
| 77 | MP0008004_abnormal_stomach_pH | 0.30685512 |
| 78 | MP0003195_calcinosis | 0.28173173 |
| 79 | MP0002697_abnormal_eye_size | 0.27946475 |
| 80 | MP0000609_abnormal_liver_physiology | 0.27906535 |
| 81 | MP0000026_abnormal_inner_ear | 0.27848681 |
| 82 | MP0001661_extended_life_span | 0.27706867 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.27532079 |
| 84 | MP0004043_abnormal_pH_regulation | 0.26662840 |
| 85 | MP0010030_abnormal_orbit_morphology | 0.26570527 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.26417635 |
| 87 | MP0004924_abnormal_behavior | 0.25933439 |
| 88 | MP0005386_behavior/neurological_phenoty | 0.25933439 |
| 89 | MP0005646_abnormal_pituitary_gland | 0.25718670 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.24412639 |
| 91 | MP0001968_abnormal_touch/_nociception | 0.24267620 |
| 92 | MP0009745_abnormal_behavioral_response | 0.24233633 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.23129039 |
| 94 | MP0005334_abnormal_fat_pad | 0.22044573 |
| 95 | MP0003879_abnormal_hair_cell | 0.22023429 |
| 96 | MP0009764_decreased_sensitivity_to | 0.21888749 |
| 97 | MP0005266_abnormal_metabolism | 0.20436112 |
| 98 | MP0005535_abnormal_body_temperature | 0.20244547 |
| 99 | MP0004742_abnormal_vestibular_system | 0.19393682 |
| 100 | MP0004142_abnormal_muscle_tone | 0.19199302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.45745195 |
| 2 | Chorioretinal atrophy (HP:0000533) | 8.95599101 |
| 3 | Pigmentary retinal degeneration (HP:0001146) | 8.95231462 |
| 4 | Central scotoma (HP:0000603) | 8.23985958 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 7.68894332 |
| 6 | Pendular nystagmus (HP:0012043) | 7.31629931 |
| 7 | Dyschromatopsia (HP:0007641) | 7.29137917 |
| 8 | Scotoma (HP:0000575) | 7.08506583 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 7.02456204 |
| 10 | Decreased central vision (HP:0007663) | 6.56212210 |
| 11 | Abolished electroretinogram (ERG) (HP:0000550) | 6.41001853 |
| 12 | Type II diabetes mellitus (HP:0005978) | 5.42043121 |
| 13 | Photophobia (HP:0000613) | 5.37887567 |
| 14 | Keratoconus (HP:0000563) | 5.27766506 |
| 15 | Increased corneal curvature (HP:0100692) | 5.27766506 |
| 16 | Cone-rod dystrophy (HP:0000548) | 5.09065891 |
| 17 | Vitreoretinal degeneration (HP:0000655) | 5.05050543 |
| 18 | Severe visual impairment (HP:0001141) | 4.96107356 |
| 19 | Macular degeneration (HP:0000608) | 4.53156380 |
| 20 | Retinitis pigmentosa (HP:0000510) | 4.38311582 |
| 21 | Constricted visual fields (HP:0001133) | 4.09591049 |
| 22 | Choroideremia (HP:0001139) | 4.02505760 |
| 23 | Posterior subcapsular cataract (HP:0007787) | 4.01155174 |
| 24 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.60633998 |
| 25 | Progressive visual loss (HP:0000529) | 2.89359401 |
| 26 | Retinal atrophy (HP:0001105) | 2.76762061 |
| 27 | Gait imbalance (HP:0002141) | 2.58052132 |
| 28 | Congenital primary aphakia (HP:0007707) | 2.56630026 |
| 29 | Optic disc pallor (HP:0000543) | 2.55744219 |
| 30 | Subcapsular cataract (HP:0000523) | 2.50197848 |
| 31 | Wide nasal bridge (HP:0000431) | 2.33815180 |
| 32 | Nephrogenic diabetes insipidus (HP:0009806) | 2.31850200 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.22953620 |
| 34 | Congenital sensorineural hearing impairment (HP:0008527) | 2.22689318 |
| 35 | Poor coordination (HP:0002370) | 2.03737142 |
| 36 | Congenital stationary night blindness (HP:0007642) | 15.7344060 |
| 37 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.1221408 |
| 38 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.1026649 |
| 39 | Severe Myopia (HP:0011003) | 1.72954813 |
| 40 | Vaginal atresia (HP:0000148) | 1.69700303 |
| 41 | Genital tract atresia (HP:0001827) | 1.66252397 |
| 42 | Optic atrophy (HP:0000648) | 1.63028343 |
| 43 | Hypoplasia of the fovea (HP:0007750) | 1.60323604 |
| 44 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.60323604 |
| 45 | True hermaphroditism (HP:0010459) | 1.58415709 |
| 46 | Epileptic encephalopathy (HP:0200134) | 1.54990574 |
| 47 | Febrile seizures (HP:0002373) | 1.53340292 |
| 48 | Abnormality of the fovea (HP:0000493) | 1.52834538 |
| 49 | Dysdiadochokinesis (HP:0002075) | 1.52284894 |
| 50 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.42070163 |
| 51 | Cholecystitis (HP:0001082) | 1.36018217 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 1.36018217 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 1.35259127 |
| 54 | Septo-optic dysplasia (HP:0100842) | 1.33558243 |
| 55 | Pancreatic fibrosis (HP:0100732) | 1.33144220 |
| 56 | Polar cataract (HP:0010696) | 1.31314135 |
| 57 | Astigmatism (HP:0000483) | 1.29639530 |
| 58 | Horizontal nystagmus (HP:0000666) | 1.29377393 |
| 59 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.28013547 |
| 60 | Intrahepatic cholestasis (HP:0001406) | 1.20030472 |
| 61 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.17095150 |
| 62 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.11277683 |
| 63 | Pancreatic cysts (HP:0001737) | 1.10267787 |
| 64 | Cerebellar dysplasia (HP:0007033) | 1.07555556 |
| 65 | Left ventricular hypertrophy (HP:0001712) | 1.03403824 |
| 66 | Cystic liver disease (HP:0006706) | 1.03046757 |
| 67 | Chorioretinal coloboma (HP:0000567) | 1.02311156 |
| 68 | Broad foot (HP:0001769) | 1.01157980 |
| 69 | Albinism (HP:0001022) | 0.98158844 |
| 70 | Specific learning disability (HP:0001328) | 0.97769755 |
| 71 | Decreased testicular size (HP:0008734) | 0.95904095 |
| 72 | Progressive cerebellar ataxia (HP:0002073) | 0.95680996 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 0.94991868 |
| 74 | Asthma (HP:0002099) | 0.93969952 |
| 75 | Recurrent sinusitis (HP:0011108) | 0.92664544 |
| 76 | Retinal detachment (HP:0000541) | 0.92020890 |
| 77 | Chronic hepatic failure (HP:0100626) | 0.90566517 |
| 78 | Deep venous thrombosis (HP:0002625) | 0.90368715 |
| 79 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 0.89864739 |
| 80 | Hyperlipoproteinemia (HP:0010980) | 0.88324851 |
| 81 | Truncal ataxia (HP:0002078) | 0.88285346 |
| 82 | Absence seizures (HP:0002121) | 0.87922357 |
| 83 | Partial agenesis of the corpus callosum (HP:0001338) | 0.82458992 |
| 84 | Prolonged QT interval (HP:0001657) | 0.82095587 |
| 85 | Prolonged partial thromboplastin time (HP:0003645) | 0.81525073 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.81374386 |
| 87 | Hypobetalipoproteinemia (HP:0003563) | 0.77975041 |
| 88 | Xanthomatosis (HP:0000991) | 0.77157459 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 0.76781187 |
| 90 | EEG with generalized epileptiform discharges (HP:0011198) | 0.75241903 |
| 91 | Generalized myoclonic seizures (HP:0002123) | 0.74591720 |
| 92 | Abnormality of the lower motor neuron (HP:0002366) | 0.73572256 |
| 93 | Sclerocornea (HP:0000647) | 0.73035670 |
| 94 | Congenital hepatic fibrosis (HP:0002612) | 0.72773287 |
| 95 | Short foot (HP:0001773) | 0.72371882 |
| 96 | Furrowed tongue (HP:0000221) | 0.70918600 |
| 97 | Epileptiform EEG discharges (HP:0011182) | 0.70915455 |
| 98 | Hypolipoproteinemia (HP:0010981) | 0.70692621 |
| 99 | Abnormality of midbrain morphology (HP:0002418) | 0.70085686 |
| 100 | Molar tooth sign on MRI (HP:0002419) | 0.70085686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 8.55560571 |
| 2 | GRK1 | 8.40449783 |
| 3 | PINK1 | 3.40627808 |
| 4 | INSRR | 2.96810811 |
| 5 | IRAK2 | 2.45187926 |
| 6 | NEK1 | 1.86354029 |
| 7 | TAOK3 | 1.86147917 |
| 8 | AKT3 | 1.55354099 |
| 9 | SGK494 | 1.51799553 |
| 10 | SGK223 | 1.51799553 |
| 11 | ERBB3 | 1.42727458 |
| 12 | SIK2 | 1.29153871 |
| 13 | CAMK1D | 1.27195870 |
| 14 | SGK2 | 1.23681930 |
| 15 | MAPK7 | 1.22640735 |
| 16 | ADRBK1 | 1.20237822 |
| 17 | STK38 | 1.19742629 |
| 18 | MAPK12 | 1.19516198 |
| 19 | MARK1 | 1.18866866 |
| 20 | CAMK1G | 1.15944017 |
| 21 | BRD4 | 1.14527811 |
| 22 | PRKAA1 | 1.09323659 |
| 23 | PLK2 | 1.06645374 |
| 24 | PRKCZ | 1.05245101 |
| 25 | DYRK1A | 1.04910408 |
| 26 | SGK3 | 1.00896140 |
| 27 | ERBB2 | 0.98529051 |
| 28 | EPHA3 | 0.98484626 |
| 29 | HIPK2 | 0.94770677 |
| 30 | MAP3K4 | 0.94261641 |
| 31 | SIK1 | 0.92943224 |
| 32 | PAK6 | 0.92555609 |
| 33 | CDK3 | 0.92193373 |
| 34 | MAP3K7 | 0.88869489 |
| 35 | LATS1 | 0.87650631 |
| 36 | CAMK2D | 0.85177891 |
| 37 | ICK | 0.84862022 |
| 38 | STK38L | 0.84788931 |
| 39 | CSNK1D | 0.81105888 |
| 40 | TAOK2 | 0.77119078 |
| 41 | RPS6KA4 | 0.76734802 |
| 42 | FES | 0.72134937 |
| 43 | CCNB1 | 0.71911636 |
| 44 | PRPF4B | 0.70281523 |
| 45 | MAP3K10 | 0.69885816 |
| 46 | CAMKK1 | 0.66558442 |
| 47 | PRKACG | 0.65074641 |
| 48 | BMPR2 | 0.64459216 |
| 49 | PRKCB | 0.64156399 |
| 50 | PRKAA2 | 0.64149033 |
| 51 | TNK2 | 0.64050049 |
| 52 | PHKG1 | 0.62353448 |
| 53 | PHKG2 | 0.62353448 |
| 54 | PLK4 | 0.61297287 |
| 55 | NEK6 | 0.60283156 |
| 56 | CDK9 | 0.59458237 |
| 57 | DYRK1B | 0.58478777 |
| 58 | PRKCH | 0.58195428 |
| 59 | RPS6KA3 | 0.55019464 |
| 60 | NEK2 | 0.53734129 |
| 61 | PRKD3 | 0.52409580 |
| 62 | RIPK1 | 0.47041325 |
| 63 | MAP3K13 | 0.46930989 |
| 64 | PKN1 | 0.46171932 |
| 65 | MINK1 | 0.45894964 |
| 66 | CAMK1 | 0.44607912 |
| 67 | MAP2K4 | 0.43645693 |
| 68 | CAMK4 | 0.43527549 |
| 69 | CAMK2A | 0.43054720 |
| 70 | PRKCG | 0.42849439 |
| 71 | GSK3B | 0.42729546 |
| 72 | CDK12 | 0.42549404 |
| 73 | SGK1 | 0.41828172 |
| 74 | PRKACA | 0.38317402 |
| 75 | NME1 | 0.38107210 |
| 76 | MAP2K7 | 0.37207402 |
| 77 | PRKCA | 0.37061389 |
| 78 | PLK3 | 0.36841870 |
| 79 | MAPK14 | 0.36671200 |
| 80 | MAPK10 | 0.35611860 |
| 81 | GRK5 | 0.35054775 |
| 82 | RPS6KB1 | 0.33971135 |
| 83 | PRKDC | 0.33811409 |
| 84 | CDK5 | 0.33601867 |
| 85 | MAPK9 | 0.33491859 |
| 86 | EPHA4 | 0.32346692 |
| 87 | FER | 0.28885978 |
| 88 | FRK | 0.26724729 |
| 89 | BCKDK | 0.26665103 |
| 90 | PRKG1 | 0.26612214 |
| 91 | TTK | 0.25700299 |
| 92 | AKT2 | 0.25635377 |
| 93 | CDK1 | 0.25213572 |
| 94 | PKN2 | 0.23779282 |
| 95 | YES1 | 0.23579550 |
| 96 | MAPK8 | 0.23492670 |
| 97 | MAPK3 | 0.23168638 |
| 98 | PRKD2 | 0.22984598 |
| 99 | FGFR4 | 0.22584909 |
| 100 | WNK1 | 0.21178510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 14.6003452 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80071328 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.71605342 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 1.52502141 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 1.52445137 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47824533 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 1.35027339 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23142623 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22999041 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19454854 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.04264674 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.01304490 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 1.00920702 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95041306 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92742579 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87625801 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86466682 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82061495 |
| 19 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79016066 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78159214 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 0.76171728 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75068816 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74521273 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74110681 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73169065 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.71726791 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 0.62065955 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61226453 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60321985 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59977320 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.59261121 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 0.58325464 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55615888 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53461397 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50055640 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49459856 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48456655 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48067173 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47859778 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 0.47772488 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47030622 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47002147 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45734865 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44190548 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43876995 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 0.42812854 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42719604 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42697661 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40144798 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 0.40065231 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39621336 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38317149 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38080320 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37478507 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36848458 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36584299 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36031962 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35960308 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.35434283 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35317160 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.35162147 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34493481 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34119032 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34048765 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.33081403 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32094956 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31926130 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31296678 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31275627 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30738566 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30671417 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30327519 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.27482646 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27218053 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26859049 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.25705241 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.25658296 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24890762 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24329656 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23751145 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23508098 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23500594 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23305788 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22214124 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21528063 |
| 86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.21273943 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20917658 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.20503455 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20381474 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.20210347 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19376263 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18985674 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.18921534 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18631723 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.18294563 |
| 96 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.18190414 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.15492109 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.14805993 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14575867 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.14412051 |

